McMaster Health Forum, McMaster University, 1280 Main St W MML-417, Hamilton, ON, L8S 4L6, Canada.
Health Policy PhD Program, McMaster University, 1280 Main St W 2C Area, Hamilton, ON, L8S 4K1, Canada.
Implement Sci. 2024 Sep 27;19(1):67. doi: 10.1186/s13012-024-01396-2.
BACKGROUND: The COVID-19 pandemic has had an unprecedented impact in the global research production and has also increased research waste. Living evidence syntheses (LESs) seek to regularly update a body of evidence addressing a specific question. During the COVID-19 pandemic, the production and dissemination of LESs emerged as a cornerstone of the evidence infrastructure. This critical interpretive synthesis answers the questions: What constitutes an LES to support decision-making?; when should one be produced, updated, and discontinued?; and how should one be disseminated? METHODS: Searches included the Cochrane Library, EMBASE (Ovid), Health Systems Evidence, MEDLINE (Ovid), PubMed, and Web of Science up to 23 April 2024 and included articles that provide any insights on addressing the compass questions on LESs. Articles were selected and appraised, and their insights extracted. An interpretive and iterative coding process was used to identify relevant thematic categories and create a conceptual framework. RESULTS: Among the 16,630 non-duplicate records identified, 208 publications proved eligible. Most were non-empirical articles, followed by actual LESs. Approximately one in three articles were published in response to the COVID-19 pandemic. The conceptual framework addresses six thematic categories: (1) what is an LES; (2) what methodological approaches facilitate LESs production; (3) when to produce an LES; (4) when to update an LES; (5) how to make available the findings of an LES; and (6) when to discontinue LES updates. CONCLUSION: LESs can play a critical role in reducing research waste and ensuring alignment with advisory and decision-making processes. This critical interpretive synthesis provides relevant insights on how to better organize the global evidence architecture to support their production. TRIAL REGISTRATION: PROSPERO registration: CRD42021241875.
背景:COVID-19 大流行对全球研究产出产生了前所未有的影响,同时也增加了研究浪费。实时证据综合(LES)旨在定期更新针对特定问题的证据体。在 COVID-19 大流行期间,LES 的制作和传播成为证据基础架构的基石。本关键性解释性综合回答了以下问题:支持决策的 LES 是什么构成的?应该何时制作、更新和停止?以及应该如何传播?
方法:检索范围包括 Cochrane 图书馆、EMBASE(Ovid)、卫生系统证据、MEDLINE(Ovid)、PubMed 和 Web of Science,检索时间截至 2024 年 4 月 23 日,包括提供任何关于 LES 指南针问题的见解的文章。选择和评估文章,并提取其见解。使用解释性和迭代编码过程来确定相关主题类别并创建概念框架。
结果:在 16630 份非重复记录中,有 208 篇文章符合条件。大多数是非实证文章,其次是实际的 LES。大约三分之一的文章是针对 COVID-19 大流行发表的。概念框架涉及六个主题类别:(1)什么是 LES;(2)哪些方法有助于 LES 的制作;(3)何时制作 LES;(4)何时更新 LES;(5)如何提供 LES 的结果;以及(6)何时停止更新 LES。
结论:LES 可以在减少研究浪费和确保与咨询和决策过程保持一致方面发挥关键作用。本关键性解释性综合提供了有关如何更好地组织全球证据架构以支持其制作的相关见解。
试验注册:PROSPERO 注册:CRD42021241875。
Cochrane Database Syst Rev. 2024-12-12
Cochrane Database Syst Rev. 2022-2-1
Cochrane Database Syst Rev. 2023-10-9
Medwave. 2020-7-28
Cochrane Database Syst Rev. 2020-6-25
Medicine (Baltimore). 2020-9-18
Z Evid Fortbild Qual Gesundhwes. 2024-5
Health Res Policy Syst. 2023-12-18
Am J Public Health. 2024-1
Public Health Pract (Oxf). 2023-10-5
Health Info Libr J. 2023-11-9
Front Pharmacol. 2023-8-24